SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

ADXS Board of Directors, please consider putting the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
fbg0316 Member Profile
 
Followed By 7
Posts 2,955
Boards Moderated 0
Alias Born 12/14/09
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 11/9/2017 5:25:39 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 6:02:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 5:56:10 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 5:52:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/12/2017 3:55:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 4:31:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 4:31:51 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/27/2017 8:51:46 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2017 5:26:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2017 4:55:48 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference "Business Wire" - 9/18/2017 9:02:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/11/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 4:07:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
fbg0316   Tuesday, 08/22/17 10:26:25 AM
Re: None
Post # of 43988 
ADXS Board of Directors, please consider putting the company on the auction block and selling for $20 to $25 ($800 million to $1 billion valuation). Arguably, this would be in the best interest of 1) patients (getting the constructs to market faster with trial execution done by the expertise of a larger pharma or biotech) and 2) ADXS investors (who are down 50% from the recapitalization price of $12 over the last four years). Why risk putting into place another CEO who turns out to fumble in advancing the platform (Moore) or one who turns out to be unethical and puts his personal financial interests above shareholder interests (O'Connor). In the latest corporate presentation, you cite around $1 billion of potential future deal value based on current collaborations - you should be able to sell the entire company for approximately this value ($20 to $25 share price). Do what's right for the company, its patients and investors.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist